What the urologist should know about the female infertility evaluation

Urologic Clinics of North America

Volumn 29, Issue 4, 2002, Pages 983-992

  Brugh III, Victor M ^a   Nudell, David M ^a   Lipshultz, Larry I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORPUS LUTEUM FUNCTION; ENDOSCOPY; FEMALE INFERTILITY; HORMONAL REGULATION; HUMAN; HYSTEROSALPINGOGRAPHY; INFERTILITY THERAPY; OVULATION INDUCTION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUAL INTERCOURSE; UROLOGY;

ADULT; CLINICAL COMPETENCE; DIAGNOSTIC TECHNIQUES, UROLOGICAL; FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED;

EID: 0036865796     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00087-3     Document Type: Review

References (56)

1. Mangal RK, Carson SA, Buster JE. Evaluation of the infertile woman. In: Glover TD, Barrat CLR, editors. Male Fertility and Infertility. Cambridge: Cambridge University Press; 1999. p. 162-79.
2. Hanson MA, Dumesic DA. Initial evaluation and treatment of infertility in a primary-care setting. Mayo Clin Proc 1998;73(7):681-5.
3. Rosene-Montella K, Keely E, Laifer SA, et al. Evaluation and management of infertility in women: The internists' role. Ann Intern Med 2000;132(12):973-81.
4. Goldsmith MF. Will exercise help keep women away from oncologists-or obstetricians? JAMA 1988;259(12):1769-70.
5. Swenson I, Havens B. Menarche and menstruation, a review of the literature. J Community Health Nurs 1987;4(4):199-210.
6. Broekmans FJ, Scheffer GJ, Bancsi LF, et al. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas 1998;30(2):205-14.
7. Laurent SL, Thompson SJ, Addy C, et al. An epidemiologic study of smoking and primary infertility in women. Fertil Steril 1992;57(3):565-72.
8. Stillman RJ, Rosenberg MJ, Sachs BP. Smoking and reproduction. Fertil Steril 1986;46(4):545-66.
9. US Department of Health and Human Services. Female: Pregnancy and pregnancy outcome. In: The Health and Benefits of Smoking Cessation: A Report of the Surgeon General. Washington, DC, US. Department of Health and Human Services, 1990, Publication no. (CDC) 90-8416. p 371-423.
10. Feichtinger W. Environmental factors and fertility. Hum Reprod 1991;6(8):1170-5.
11. Bracken MB, Hellenbrand KG, Holford TR. Conception delay after oral contraceptive use: The effect of estrogen dose. Fertil Steril 1990;53(1):21-7.
12. Speroff L, Glass RH, Kase NG. Female infertility. In: Clinical Gynecologic Endocrinology and Infertility. 6th Edition. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 1013-42.
13. Jick H, Porter J. Relationship between smoking and age of natural menopause, report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977;1(8026):1354-5.
14. Navot D, Bergh PA, Williams MA, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991;337(8754):1375-7.
15. Johannisson E, Landgren BM, Rohr HP, et al. Endometrial morphology and peripheral hormone levels in women with regular menstrual cycles. Fertil Steril 1987;48(3):401-8.
16. Mattison DR. The effects of smoking on fertility from gametogenesis to implantation. Environ Res 1982;28(2):410-33.
17. Downs KA, Gibson M. Basal body temperature graph and the luteal phase defect. Fertil Steril 1983;40(4):466-8.
18. Nulsen J, Wheeler C, Ausmanas M, et al. Cervical mucus changes in relationship to urinary luteinizing hormone. Fertil Steril 1987;48(5):783-6.
19. O'Connor JF, Kovalevskaya G, Berken S, et al. The expression of the urinary forms of human luteinizing hormone beta fragment in various populations as assessed by a specific immunoradiometric assay. Hum Reprod 1998;13(4):826-35.
20. Shoupe D, Mishell DR, Lacarra M, et al. Correlation of endometrial maturation with four methods of estimating day of ovulation. Obstet Gynecol 1989;73(1):88-92.
21. Shangold M, Berkeley A, Gray J. Both midluteal serum progesterone levels and late luteal endometrial histology should be assessed in all infertile women. Fertil Steril 1983;40(5):627-30.
22. Daly DC, Walters CA, Soto-Albors CE, et al. Endometrial biopsy during treatment of luteal phase defects is predictive of therapeutic outcome. Fertil Steril 1983;40(30):305-10.
23. Collins W, Jurkovic D, Boume T, et al. Ovarian morphology, endocrine function and intra-follicular blood flow during the peri-ovulatory period. Hum Reprod 1991;6(3):319-24.
24. Gysler M, March CM, Mishell Jr DR, et al. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982;37(2):161-7.
25. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983;62(2):196-202.
26. Glatstein IZ, Harlow BL, Hornstein MD. Practice patterns among reproductive endocrinologists: The infertility evaluation. Fertil Steril 1997;67(3):443-52.
27. Gillespie HW. The therapeutic aspect of hysterosalpingography. Br J Radiol 1965;38:301.
28. Rasmussen F, Lindequist S, Larsen C, et al. Therapeutic effect of hysterosalpingography; oil versus water soluble contrast media - A randomized prospective study. Radiology 1991;179(1):75-8.
29. Mol BWG, Swart P, Bossuyt PMM, et al. Is hysterosalpingogram an important tool in predicting fertility outcome? Fertil Sterl 1997;67(4):663-9.
30. Swart P, Mol BW, van der Veen F, et al. The accuracy of hysterosalpingography in the diagnosis of tubal pathology, a meta-analysis. Fertil Steril 1995;64(3):486-91.
31. Chenia F, Hofmeyr GJ, Moolla S, et al. Sonographic hydrotubation using agitated saline: A new technique for improving fallopian tube visualization. Br J Radiol 1997;70(836):833-6.
32. Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalphingography in patients with uterine cavity diseases. Fertil Steril 2000;73(2):406-11.
33. Dijkman AB, Mol BW, van der Veen F, et al. Can hysterosalpingocontrast-sonography replace hysterosalpingography in the assessment of tubal subfertility? Eur J Radiol 2000;35(1):44-8.
34. Wiesner W, Ruehm SG, Bongartz A, et al. Three-dimensional dynamic MR hysterosalpingography: A preliminary report. Eur Radiol 2001;11(8):1439-44.
35. El-Yahia AW. Laparoscopic evaluation of apparently normal infertile women. Aust N Z J Obstet Gynaecol 1994;34(4):440-2.
36. Hughes E, Fedorkow D, Collins J, et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev (2): CD000155, 2000.
37. Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997;337(4):217-22.
38. Penzias AS. Infertility: Contemporary office-based evaluation and treatment. Obstet Gynecol Clin North Am 2000;27(3):473-86.
39. Surrey ES. Microendoscopy of the human fallopian tube. J Am Assoc Gynecol Laparosc 1999;6(4):383-9.
40. Prevedourakis C, Loutradis D, Kalianidis C, et al. Hysterosalpingography and hysteroscopy in female infertility. Hum Reprod 1994;9(12):2353-5.
41. Raziel A, Arieli S, Bukovsky I, et al. Investigation of the uterine cavity in recurrent aborters. Fertil Steril 1994;62(5):1080-2.
42. Wang CW, Lee CL, Lai YM, et al. Comparison of hysterosalpingography and hysteroscopy in female infertility. J Am Assoc Gynecol Laparosc 1996;3(4):581-4.
43. The ESHRE Capri Workshop Group. Optimal use of infertility diagnostic test and treatments. Hum Reprod 2000;15(3):723-32.
44. Westrom I. Incidence prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138(7 pt 2):880-92.
45. Moore DE, Spadoni LR, Foy HM, et al. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet 1982;2(8298):574-7.
46. Mol BW, Dijkman B, Wertheim P, et al. The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: A meta-analysis. Fertil Steril 1997;67(6):1031-7.
47. Land JA, Evers JL, Goossens VJ. How to use chlamydia antibody testing in subfertility patients. Hum Reprod 1998;13(4):1094-8.
48. Mol BWJ, Collins JA, Van Der Veen F, et al. Costeffectiveness of hysterosalpingography, laparoscopy and chlamydia antibody testing in subfertile couples. Fertil Steril 2000;75(3):571-80.
49. Hull MG, Savage PE, Bromham DR. Prognostic value of the postcoital test: Prospective study based on time-specific conception rates. Br J Obstet Gynaecol 1982;89(4):299-305.
50. Balasch J, Jove I, Ballesca JL, et al. Human in vitro fertilization in couples with unexplained infertility and a poor postcoital test. Gynecol Endocrinol 1989;3(4):289-95.
51. Hull MG, Joyce DN, McLeod FN, et al. Human in-vitro fertilization, in-vivo sperm penetration of cervical mucus and unexplained infertility. Lancet 1987;2(8397):245-6.
52. Check JH, Bollendorf A, Zaccardo, et al. Intrauterine insemination for cervical and male factor without superovulation. Arch Androl 1995;35(2):135-41.
53. Levi AJ, Raynault MF, Bergh PA, et al. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76(4):666-9.
54. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1987;2(8560):645-7.
55. Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51(4):651-4.
56. Frattarelli JL, Bergh PA, Drews MR, et al. Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril 2000;74(3):518-24.